| BIOPHYTIS NAM. EO -,002 |
| Frankreich |
| Gesundheit |
| FR001400OLP5 / A403QV |
| 6XB3 (Frankfurt) |
| FRA:6XB3, ETR:6XB3, 6XB3:GR |
| - |
| https://www.biophytis.com.. |
|
Biophytis S.A. is a clinical-stage biotechnology company that is primarily focused on developing therapies for age-related diseases and chronic conditions. Headquartered in Paris, France, and with operations extending to the United States, Biophytis ..
>Volltext.. |
| 1.54 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| BIOPHYTIS |
| 05.04.26 |
|